Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Hypertension. 2016 Dec 19;69(2):236–242. doi: 10.1161/HYPERTENSIONAHA.116.08436

Figure 4. Uric acid and Development of Major Adverse Cardiovascular Events (MACE).

Figure 4

Patients who developed MACE on follow-up had significantly higher uric acid levels than patients who did not develop MACE.